knowledge -WSS

knowledge

author：knowledge 2025-09-05 13:46:40 - browse：33

UnitedHealth's CEO Andrew Witty stares into the camera at a hearing with his fingers locked — politics coverage from STAT — Kent Nishimura/Getty Images

On Wednesday, UnitedHealth CEO Andrew Witty appeared before Congress to answer for what lawmakers called a “single attack [that] kicked off a cascading series of crises that are unmasking some deep vulnerabilities in the core of our health care system”: the February Change Healthcare cyberattack that is still disrupting payment processing across the country.

Senators repeatedly interrupted Witty, trying to keep him to concrete answers and promises. Lawmakers on both sides of the aisle were exasperated with UnitedHealth. At one point, Sen. Thom Tillis (R-N.C.) held up a fifth-edition copy of “Hacking for Dummies” during the hearing.

“This is some basic stuff that was missed,” he said, referring to the fact that the hackers gained access to a Change server that didn’t have multi-factor authentication, a big problem for a company whose business is digital data. “So shame on internal audit, external audit and your system folks, those tasked with redundancy, they’re not doing their job. And as a result, we have a data breach.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： AstraZeneca to buy developer of next

focus

WSS

Gene editing the human germline: What are the risks?

5 to watch: Tech startups trying to solve health care's staffing crisis

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

App could help diagnose ear infections more accurately — and at home

5 to watch: Tech startups trying to solve health care's staffing crisis

FogPharma raises $145 million in rare Series E round

hotspot

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

entertainment

Continuity nursing helped my family in our darkest PICU moments

A Q&A with Aletha Maybank, AMA’s chief health equity officer

New air purifier tech could be key to improving indoor air quality

CVS Caremark has created a new ploy: the drug ‘rebate credit’

BioMarin wins approval for gene therapy to treat hemophilia A

Kenai launches with $82 million for Parkinson’s stem cell therapy

Peter Hotez and the public health issue of online harassment

Gene editing the human germline: What are the risks?

Hollywood unions extend contract negotiations for actors

Biotech companies concerned about China biosecurity crackdown

leisure time

An inside look at PIPEs, biotech's buzzy new financing tool

Neuroscience’s long legacy of racism

Intermittent fasting comes with a heart risk? Not so fast

U.K. not yet recommending Vertex's CRISPR therapy for sickle cell

AstraZeneca loses challenge to Medicare drug price negotiation

Gene editing the human germline: What are the risks?

hotspot

hotspot

focus

hotspot